Cutting-Edge issues in celiac disease and in gluten intolerance

Clinical Reviews in Allergy and Immunology

Volumn 42, Issue 3, 2012, Pages 279-287

  Bizzaro, N ^a,e   Tozzoli, R ^b   Villalta, D ^c   Fabris, M ^d   Tonutti, E ^d  

^a S Antonio Hospital   (Italy)

^b Civic Hospital   (Italy)

^c S MARIA DEGLI ANGELI HOSPITAL   (Italy)

^d SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

^e Ospedale S Antonio   (Italy)

Author keywords

Celiac disease; Cytokines; Gluten sensitivity; Neoepitopes

Indexed keywords

ALPHA INTERFERON; ENDOMYSIUM ANTIBODY; F ACTIN; GAMMA INTERFERON; GLIADIN ANTIBODY; GLUTEN; IMMUNOGLOBULIN A ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 21; INTERLEUKIN 23; INTERLEUKIN 27; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 8; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY;

ANTIBODY DETECTION; CD3+ T LYMPHOCYTE; CELIAC DISEASE; CYTOKINE PRODUCTION; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GLUTEN FREE DIET; HAPLOTYPE; HUMAN; INNATE IMMUNITY; INTESTINE BIOPSY; INTESTINE MUCOSA PERMEABILITY; LABORATORY DIAGNOSIS; MOLECULAR MECHANICS; PREDICTIVE VALUE; REVIEW; SENSITIVITY AND SPECIFICITY;

ANIMALS; AUTOANTIGENS; CELIAC DISEASE; CYTOKINES; GLIADIN; GLUTENS; HUMANS; TRANSGLUTAMINASES;

EID: 84865276400     PISSN: 10800549     EISSN: 15590267     Source Type: Journal    
DOI: 10.1007/s12016-010-8223-1     Document Type: Review

References (96)

1. Catassi C, Ratsch IM, Fabiani E et al (1994) Coeliac disease in the year 2000: Exploring the iceberg. Lancet 343:200-203
2. Rostom A, Murray JA, Kagnoff MF (2006) American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. Gastroenterology 131:1981-2002
3. Rostom A, Dubè C, Cranney A et al (2005) The diagnostic accuracy of serological test for celiac disease: A systematic review. Gastroenterology 128:S38-S46
4. Not T, Horvath K, Hill ID et al (1998) Celiac disease risk in the USA: High prevalence of antiendomysium antibodies in healthy blood donors. Scand J Gastroenterol 33:494-498
5. Dieterich W, Laag E, Schopper H et al (1998) Autoantibodies to tissue transglutaminase as predictors of celiac disease. Gastroenterology 115:1317-1321
6. Tonutti E, Visentini D, Bizzaro N et al (2003) The role of antitissue transglutaminase assay for the diagnosis and monitoring of coeliac disease: A French-Italian multicentre study. J Clin Pathol 56:389-393
7. Mustalahti K, Catassi C, Reunanen A, Coeliac EU Cluster, Project Epidemiology et al (2010) The prevalence of celiac disease in Europe: Results of a centralized, international mass screening project. Ann Med 42:587-595
8. Catassi C, Kryszak D, Bhatti B et al (2010) Natural history of celiac disease autoimmunity in a USA cohort followed since. Ann Med 42:530-538
9. Lohi S, Mustalahti K, Kaukinen K et al (2007) Increasing prevalence of coeliac disease over time. Aliment Pharmacol Ther 26:1217-1225
10. Kurrpa K, Ashorn M, Iltanen S et al (2010) Celiac disease without villous atrophy in children: A prospective study. J Pediatr 157 (3):378.e1-380.e1
11. Hill ID, Dirks MH, Liptak GS et al (2005) Guideline for the diagnosis and treatment of celiac disease in children: Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Ped Gastroenterol Nutr 40:119
12. Sjostrom H, Lundin KEA, Molberg O et al (1998) Identification of a gliadin T cell epitope in coeliac disease: General importance of gliadin deamidation for intestinal T recognition. Scand J Immunol 48:111-115
13. Molberg O, McAdam SN, Korner R et al (1998) Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med 4:713-717
14. Aleanzi M, Demonte AM, Esper C, Garcilazo S, Waggener M (2001) Celiac disease: Antibody recognition against native and selectively deamidated gliadin peptides. Clin Chem 47:2023-2028
15. Schwertz E, Kahlenberg F, Sack U et al (2004) Serological assay based on gliadin-related nonapeptides as a highly sensitive and specific diagnostic aid in celiac disease. Clin Chem 50:2370-2375
16. Sugai E, Vazquez H, Nachman F et al (2006) Accuracy of testing for antibodies to synthetic gliadin-peptides in celiac disease. Clin Gastroenterol Hepatol 4:1112-1117
17. Kaukinen K, Collin P, Laurila K, Kaartinen T, Partanen J, Maki M (2007) Resurrection of gliadin antibodies in coeliac disease. Deamidated gliadin peptide antibody test provides additional diagnostic benefit. Scand J Gastroenterol 42:1428-1433
18. Niveloni S, Sugai E, Cabanne A, Vazquez H, Argonz J, Smecuol E et al (2007) Antibodies against synthetic deamidated gliadina peptides as predictors of celiac disease: Prospective assessment in an adult population with a high pretest probability of disease. Clin Chem 53:2186-2192
19. Carlsson AK, Axelsson IE, Borulf SK et al (2001) Serological screening for celiac disease in healthy 2.5-year-old children in Sweden. Pediatrics 107:42-45
20. Lagerqvist C, Dahlbom I, Hansson T et al (2008) Antigliadin immunoglobulin A best in finding celiac disease in children younger than 18 months of age. J Ped Gastroenterol Nutr 47:428-435
21. Maglio M, Tosco A, Paparo F et al (2010) Serum and intestinal celiac disease-associated antibodies in children with celiac disease younger than 2 years of age. J Ped Gastroenterol Nutr 50:43-48
22. Simell S, Kupila A, Hoppu S et al (2005) Natural history of transglutaminase autoantibodies and mucosal changes in children carrying HLA-conferred celiac disease susceptibility. Scand J Gastroenterol 40:1182-1191
23. Liu E, LI M, Emery L, Taki I, Barriga K, Tiberti C et al (2007) Natural history of antibodies to deamidated gliadin peptides and transglutaminase in early childhood celiac disease. J Ped Gastroenterol Nutr 45:293-300
24. Agardh D (2007) Antibodies against synthetic deamidated gliadin peptides and tissue transglutaminase for the identification of childhood celiac disease. Clin Gastroenterol Hepatol 5:1276-1281
25. Basso D, Guariso G, Fogar P et al (2009) Antibodies against synthetic deamidated gliadin peptides for celiac disease diagnosis and follow-up in children. Clin Chem 55:150-157
26. Naiyer AJ, Hernandez L, Ciaccio EJ et al (2009) Comparison of commercially available serologic kits for the detection of celiac disease. J Clin Gastroenterol 43:225-232
27. Villalta D, Alessio MG, Tampoia M et al (2007) Testing for IgG class antibodies in celiac disease patients with selective IgA deficiency. A comparison of the diagnostic accuracy of 9 IgG antitissue transglutaminase, 1 IgG anti-gliadin and 1 IgG anti-deamidated gliadin peptide antibody assays. Clin Chim Acta 382:95-99
28. Tozzoli R, Kodermaz G, Tampoia M, Visentini D, Tonutti E, Bizzaro N (2010) [Detection of autoantibodies specific for transglutaminase-gliadin peptides complex: A new way to explore the celiac iceberg?] It. J Lab Med 6:28-35
29. Clemente MG, Musu MP, Frau F et al (2000) Immune reaction against the cytoskeleton in celiac disease. Gut 47:520-526
30. Clemente MG, Musu MP, Troncone R et al (2004) Enterocyte actin antibody detection: A new diagnostic tool in celiac disease diagnosis. Results of a multicenter study. Am J Gastroenterol 99:1551-1556
31. Granito A, Muratori P, Cassani F et al (2004) Anti-actin IgA antibodies in severe coeliac disease. Clin Exp Immunol 137:386-392
32. Carroccio A, Brusca I, Iacono G et al (2005) Anti-actin antibodies in celiac disease: Correlation with intestinal mucosa damage and comparison of ELISA with the immunofluorescence assay. Clin Chem 51:917-920
33. Carroccio A, Brusca I, Iacono G et al (2007) IgA anti-actin antibodies ELISA in coeliac disease: A multicentre study. Dig Liver Dis 39:818-823
34. Tonutti E, Visentini D, Picierno A et al (2009) Diagnostic efficacy of the ELISA test for the detection of deamidated anti-gliadin peptide antibodies in the diagnosis and monitoring of celiac disease. J Clin Lab Anal 23:165-171
35. Villalta D, Tonutti E, Prause C et al (2010) IgG antibodies against deamidated gliadin peptides for diagnosis of celiac disease in patients with IgA deficiency. Clin Chem 56:464-468
36. Volta U, Fabbri A, Parisi C (2010) Deamidated gliadin peptide antibodies as a routine test for celiac disease: A prospective analysis. J Clin Gastroenterol 44:186-190
37. Tursi A, Brandimarte G, Giorgietti GM et al (2006) Endoscopic and histological findings in the duodenum of adults with celiac disease before and after changing to a gluten-free diet: A 2-year prospective study. Endoscopy 38:702-707
38. Biagi F, Pezzimenti D, Campanella J, Vadacca GB, Corazza GR (2001) Endomysial and tissue transglutaminase antibodies in coeliac sera: A comparison not influenced by previous serological testing. Scand J Gastroenterol 36:955-958
39. Lock RJ, Stevens S, Pitcher MC, Unsworth DJ (2004) Is immunoglobulin A anti-tissue transglutaminase antibody a reliable serological marker of coeliac disease?. Eur J Gastroenterol Hepatol 16:467-470
40. Baudon JJ, Johanet C, Absalon YB, Morgant G, Cabrol S, Mougenot JF (2004) Diagnosing celiac disease: A comparison of human tissue transglutaminase antibodies with antigliadin and antiendomysium antibodies. Arch Pediatr Adolesc Med 158:584-588
41. Tonutti E, Bizzaro N, Villalta D, Tozzoli R, Tampoia M (2009) Laboratory diagnosis of coeliac disease. Autoimmun Highlights 0:15-21
42. Visser J, Rozing J, Sapone A, Lammers K, Fasano A (2009) Tight junctions, intestinal permeability, and autoimmunity. Celiac disease and type 1 diabetes paradigms. Ann NY Acad Sci 1165:195-205
43. Fleckenstein B, Qiao SW, Larsen MR, Jung G, Roepstorff P, Sollid LM (2004) Molecular characterization of covalent complexes between tissue transglutaminase and gliadin peptides. J Biol Chem 79:17607-17616
44. Ciccocioppo R, Di Sabatino A, Ara C et al (2003) Gliadin and tissue transglutaminase complexes in normal and coeliac duodenal mucosa. Clin Exp Immunol 134:516-524
45. Mattias T, Pfeiffer S, Selmi C, Gershwin ME (2010) Diagnostic challenges in celiac disease and the role of the tissue transglutaminase-neo-epitope. Clin Rev Allergy Immunol 38:298-301
46. Pinkas DM, Strop P, Brunger AT, Khosla C (2007) Transglutaminase 2 undergoes a large conformational change upon activation. PLoS Biol 5:2788-2796
47. Remes-Troche JM, Ramirez-Iglesias MT, Rubio-Tapia A, Alonso-Ramos A, Velazquez A, Uscanga LF (2006) Celiac disease could be a frequent disease in Mexico: Prevalence of tissue transglutaminase antibody in healthy blood donors. J Clin Gastroenterol 40:697-700
48. Remes-Troche JM, Rios-Vaca A, Ramirez-Iglesias MT et al (2008) High prevalence of celiac disease in Mexican Mestizo adults with type 1 diabetes mellitus. J Clin Gastroenterol 42:460-465
49. Tozzoli R, Kodermaz G, Porcelli B, et al. (2010) Clinical relevance and diagnostic accuracy of a new ELISA method for the detection of autoantibodies to the gliadin-transglutaminase complex. Proceedings of the 7th International Congress on Autoimmunity, Liubljana, 5-9 May 2010
50. Tonutti E, Visentini D, Fabris M, et al. (2010) Antibodies to the transglutaminase-deamidated gliadin peptides complex: A new serological approach to the diagnosis of celiac disease. Proceedings of the 7th International Congress on Autoimmunity, Ljubljana, 5-9 May 2010
51. Reeves GEM, Squance ML, Duggan AE et al (2006) Diagnostic accuracy of celiac serological tests: A prospective study. Eur J Gastroenterol Hepatol 18:493-501
52. Catassi C, Fasano A (2008) Celiac disease. Curr Opin Gastroenterol 24:687-691
53. Anderson LA, McMillan S, Watson RG et al (2007) Maligancy and mortality in a population-based color of patients with coeliac disease or 'gluten sensitivity'. World J Gastroenterol 13:146-151
54. Kaukinen K, Tujanmmaa K, Mäki M et al (2000) Intolerance to cereals is not specific for celiac disease. Scand J Gastroenterol 35:942-946
55. Clemente MG, De Virgiliis S, Kang JS et al (2003) Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function. Gut 52:218-223
56. Sapone A, Lammers KM, Mazzarela G et al (2010) Differential mucosal IL-17 expression in two gliadin-induced disorders: Gluten sensitivity and the autoimmune enteropathy celiac disease. Int Arch Allergy Immunol 152:75-80
57. Ferguson A, Gillett H, Humphreys K, Kingstone K (1998) Heterogeneity of celiac disease: Clinical, pathological, immunological, and genetic. Ann NY Acad Sci 859:112-120
58. Catassi C, Fasano A (2008) Is this really celiac disease? Pitfalls in diagnosis. Curr Gastroenterol Rep 10:466-472
59. Fabris M, Visentini D, Da Re V et al (2007) Elevated B cell-activating factor of the tumor necrosis factor family in coeliac disease. Scand J Gastroenterol 42:1434-1439
60. Fabris M, De Vita S, Visentini D et al (2009) B-Lymphocyte stimulator and a proliferation-inducing ligand serum levels in IgA-deficient patients with and without celiac disease. Ann NY Acad Sci 1173:268-273
61. Sapone A, Giuliano MT, Cammarota M et al (2009) Gluten sensitivity is associated to activation of the innate but not adaptive immune response to gluten exposure. Gastroenterology 136(1):5-413
62. Hadjivassiliou M, Chattopadhyay AK, Grünewald RA et al (2007) Myopathy associated with gluten sensitivity. Muscle Nerve 35:443-450
63. Ford RPK (2009) The gluten syndrome: A neurological disease. Med Hypotheses 73:438-440
64. Elder JH (2008) The gluten-free, casein-free diet in autism: An overview with clinical implication. Nutr Clin Pract 23:583-588
65. Dikerson F, Stallings C, Origoni A et al (2010) Markers of gluten sensitivity and celiac disease in recent-onset psychosis and multiepisode schizophrenia. Biol Psychiatry 68:100-104
66. Verdu EF, Armstrong D, Murray JA (2009) Between celiac disease and irritable bowel syndrome: The "non man's land" of gluten sensitivity. Am J Gastroenterol 104:1587-1594
67. Meresse B, Cerf-Bensussan N (2009) Innate T cell responses in human gut. Semin Immunol 21:121-129
68. Palmer E (2007) The generation of T cell tolerance. Swiss Med Wkly 137(suppl 155):99S-100S
69. Maiuri L, Ciacci C, Ricciardelli I et al (2003) Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease. Lancet 362:30-37
70. Londei M, Ciacci C, Ricciardelli I et al (2005) Gliadin as stimulator of innate responses in celiac disease. Mol Immunol 42:913-918
71. Schuppan D, Junker Y, Barisani D et al (2009) Celiac disease: From pathogenesis to novel therapies. Gastroenterol 137:912-933
72. Meresse B, Verdier J, Cerf-Bensussan N (2008) The cytokine interleukin 21: A new player in coeliac disease?. Gut 57:879-881
73. De la Concha EG, Fernandez-Arquero M, Vigil P et al (2000) Celiac disease and TNF promoter polymorphism. Hum Immunol 61:513-517
74. Maki M, Collin P (1997) Coeliac disease. Lancet 349:200-203
75. Uibo O, Lambrechts A, Mascart-Lemone F (1995) Human oesophagus: A convenient antigenic substrate for the autoantibodies in the serological diagnosis of coeliac disease. Eur J Gastroenterol Hepatol 7:37-40
76. Catassi C (2005) Where is celiac disease coming from and why?. J Pediatr Gastroenterol Nutr 40:279-282
77. Schuppan D (2000) Current concepts of celiac disease pathogenesis. Gastroenterology 119:234-242
78. Salvati VM, Mac Donald TT, Bajaj-Elliott M et al (2002) Interleukin 18 and associated markers of T helper cell type 1 activity in coeliac disease. Gut 50:186-190
79. Przemioslo RT, Lundin KEA, Sollid LM, Nelufer J, Ciclitira PJ (1995) Histological changes in small bowel mucosa induced by gliadin sensitive T lymphocytes can be blocked by anti-interferon antibody. Gut 36:874-879
80. Leon AJ, Garrote JA, Blanco-Quiros A et al (2006) Interleukin 18 maintains a long-standing inflammation in coeliac disease patients. Clin Exp Immunol 146:479-485
81. De Nitto D, Monteleone I, Franzè E, Pallone F, Monteleone G (2009) Involvement of interleukin-15 and interleukin-21, two gamma-chain-related cytokines, in celiac disease. World J Gastroenterol 15:4609-4614
82. Garrote JA, Gomez-Gonzales E, Bernardo D, Arranz E, Chirdo F (2008) Celiac disease pathogenesis: The proinflammatory cytokine network. J Pediatr Gastroenterol Nutr 47:27-32
83. Mackay F, Mackay CR (2002) The role of BAFF in B-cell maturation, T-cell activation and autoimmunity. Trends Immunol 23:113-115
84. Mackay F, Woodcock SA, Lawton P et al (1999) Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J Exp Med 190:1697-1710
85. Sthol W (2002) B lymphocyte stimulator protein levels in systemic lupus erythematosus and other diseases. Curr Rheumatol Resp 4:345-350
86. Seyler TM, Park YW, Takemura S et al (2005) BLyS and APRIL in rheumatoid arthritis. J Clin Invest 115:3083-3092
87. Mariette X, Roux S, Zhang J et al (2003) The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjogren's syndrome. Ann Rheum Dis 62:168-171
88. Fabris M, Quartuccio L, Sacco S et al (2007) B-lymphocyte simulator (BLys) up-regulation in mixed cryoglobulinaemia syndrome and hepatitis-C virus infection. Rheumatology 46:3743
89. Nardelli B, Belvedere O, Roschke V et al (2001) Synthesis and release of B-lymphocyte stimulator from myeloid cells. Blood 97:198-204
90. Batten M, Groom J, Cachero TG et al (2000) BAFF mediates survival of peripheral immature B lymphocytes. J Exp Med 192:1453-1466
91. Daum S, Bauer U, Foss HD et al (1999) Increased expression of mRNA for matrix metalloproteases-1 and -3 and tissue inhibitor of metalloproteases-1 in intestinal biopsy specimens from patients with celiac disease. Gut 44:17-25
92. Westerholm-Ormio M, Garioch J, Ketola I, Savilahti E (2002) Inflammatory cytokines in small intestinal mucosa of patients with potential celiac disease. Clin Exp Immunol 128:94-101
93. Penedo-Pita M, Peteiro-Cartelle J (1991) Increased serum levels of interleukin-2 and soluble interleukin-2 receptor in celiac disease. J Pediatr Gastroenterol Nutr 12:50-60
94. Bianco A, Garrote JA, Arranz E, Alfonso M, Clavo C (2002) Increased serum IL-2R levels in coeliac disease are related to CD4 but not CD8 antigens. J Pediatr Gastroenterol Nutr 15:413-417
95. Cinova J, Pavlova-Jelinkova L, Smythies LE et al (2007) Gliadin peptides activate blood monocytes from patients with celiac disease. J Clin Immunol 27:201-209
96. Manavalan JS, Hernandez L, Shah JG et al (2010) Serum cytokine elevations in celiac disease: Association with disease presentation. Hum Immunol 71:50-57